Thursday, December 8, 2022
Home Tags Hapbee

Tag: Hapbee

Telehealth

With Hapbee (HAPBF) Who Needs, Drugs, Caffeine or Nicotine?

Editor / Curator -
Internet Stock Review, Yona Shtern
Client

Hapbee (HAPBF) Selects Accomplished Technology and Consumer Products Entrepreneur & Executive...

Editor / Curator -
hapbee
2021 Watch List

Adding Hapbee Tech (HAPB, HAPBF) $0.34 to Biotech Six Pack Watch...

Editor / Curator -
Hapbee
Telehealth

Interview: Scott Donnell from Hapbee (HAPB, HAPBF) on Wall Street Reporter.

Editor / Curator -
Satori Capital. Hapbee
Telehealth

Investment Manager With $1 Billion in Assets Under Management, Buys 300...

Editor / Curator -
Hapbee, EMulate, HAPB
Telehealth

A Medical Technology That Has The Highest Potential Over Any ...

Editor / Curator -
Hapbee
Telehealth

Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.

Editor / Curator -
HAPBEE
All News

Hapbee (HAPB): The Netflix of Feelings

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.

Editor / Curator -
Hapbee
All News

Hapbee’s (HAPB) Device, “Choose How You Feel.”

Editor / Curator -
12Page 1 of 2

Latest article

Iconic Brands (ICNB) Reports Revenues of $13.8 Million vs $4 Million. Bounces 40% Intraday.

All News Editor / Curator -
After a Rough Six Months in the market, Nine Month Numbers Propels the Stock 40% Higher Signaling Possible Bottoming Process. ...

Adding Silo Pharma (SILO) $3.50 to Watch List.

All News Editor / Curator -
Look What We Found! We launched the Psychedelic Stock Review a little more than a year ago and decided...

Alzheimer Drug Trials

All News Editor / Curator -
A winner is crowned in head-to-head Alzheimer's battle between Biogen's Aduhelm and Lilly - Dec 1, 2022 Eli...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.